Kolbert C P, Arruda J, Varga-Delmore P, Zheng X, Lewis M, Kolberg J, Persing D H
Division of Experimental Pathology and Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
J Clin Microbiol. 1998 Sep;36(9):2640-4. doi: 10.1128/JCM.36.9.2640-2644.1998.
The identification of methicillin-resistant staphylococcus isolates in the clinical laboratory has typically been performed by using methods that detect phenotypic expression of resistance determinants. However, these methods may be difficult to interpret and some isolates do not express resistance until selective pressure is administered. Assays that detect genetic determinants are not subject to these limitations and have been effective in distinguishing isolates that are capable of expressing the resistance phenotype. In this study, a novel branched-DNA (bDNA) hybridization assay was used to test for the mecA gene in 416 clinical staphylococcal isolates. The results were compared with those obtained by a PCR-based assay and oxacillin disk diffusion. For 155 Staphylococcus aureus and 261 coagulase-negative Staphylococcus isolates, the bDNA assay and PCR results were 100% concordant. Among the S. aureus isolates, 20 were MecA+ and 135 were MecA-. For the coagulase-negative staphylococci, 150 were MecA+ and 111 were MecA-. The results from the genotypic detection methods were compared with those obtained by oxacillin disk diffusion. No discrepancies were detected among the S. aureus isolates; however, 10 coagulase-negative isolates were MecA+ but oxacillin sensitive and 1 isolate was MecA- but oxacillin resistant. Oxacillin resistance was induced in 6 of the 10 MecA+ isolates previously classified as oxacillin sensitive. These results suggest that the bDNA method described here is a sensitive and efficient method for detection of methicillin resistance in staphylococci and that genetic detection methods may be useful for detection of potential methicillin resistance in the clinical laboratory.
临床实验室中耐甲氧西林葡萄球菌分离株的鉴定通常采用检测耐药决定子表型表达的方法。然而,这些方法可能难以解读,并且一些分离株在施加选择压力之前不会表达耐药性。检测基因决定子的检测方法不受这些限制,并且在区分能够表达耐药表型的分离株方面很有效。在本研究中,一种新型分支DNA(bDNA)杂交检测法用于检测416株临床葡萄球菌分离株中的mecA基因。将结果与基于PCR的检测法和苯唑西林纸片扩散法的结果进行比较。对于155株金黄色葡萄球菌和261株凝固酶阴性葡萄球菌分离株,bDNA检测法和PCR结果的一致性为100%。在金黄色葡萄球菌分离株中,20株为MecA阳性,135株为MecA阴性。对于凝固酶阴性葡萄球菌,150株为MecA阳性,111株为MecA阴性。将基因型检测方法的结果与苯唑西林纸片扩散法的结果进行比较。在金黄色葡萄球菌分离株中未检测到差异;然而,10株凝固酶阴性分离株为MecA阳性但对苯唑西林敏感,1株为MecA阴性但对苯唑西林耐药。先前分类为对苯唑西林敏感的10株MecA阳性分离株中有6株诱导出了苯唑西林耐药性。这些结果表明,本文所述的bDNA方法是检测葡萄球菌中甲氧西林耐药性的一种灵敏且有效的方法,并且基因检测方法可能有助于临床实验室检测潜在的甲氧西林耐药性。